Mondrian Investment Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Mondrian Investment Partners’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$8.5M	Sell	644,794 -4,019	-0.6%	-$55.5K	0.15%	54
2024 Q4	$8.97M	Sell	648,813 -61,492	-9%	-$924K	0.15%	57
2024 Q3	$11.3M	Sell	710,305 -785	-0.1%	-$12.6K	0.17%	56
2024 Q2	$11.6M	Sell	711,090 -111,645	-14%	-$1.6M	0.18%	54
2024 Q1	$12.1M	Sell	822,735 -272,070	-25%	-$3.97M	0.17%	56
2023 Q4	$15.2M	Buy	1,094,805 +14,080	+1%	+$188K	0.24%	52
2023 Q3	$14.5M	Sell	1,080,725 -255,230	-19%	-$3.45M	0.3%	48
2023 Q2	$16.9M	Sell	1,335,955 -112,570	-8%	-$1.31M	0.34%	48
2023 Q1	$16.5M	Sell	1,448,525 -14,675	-1%	-$158K	0.36%	45
2022 Q4	$15.1M	Sell	1,463,200 -36,515	-2%	-$394K	0.33%	47
2022 Q3	$15.7K	Buy	1,499,715 +19,065	+1%	+$203K	0.34%	48
2022 Q2	$16.4M	Sell	1,480,650 -24,150	-2%	-$263K	0.34%	44
2022 Q1	$16.8M	Buy	1,504,800 +28,960	+2%	+$328K	0.34%	45
2021 Q4	$19.3M	Hold	1,475,840	–	–	0.38%	46
2021 Q3	$19.2M	Hold	1,475,840	–	–	0.39%	44
2021 Q2	$21.7M	Hold	1,475,840	–	–	0.41%	45
2021 Q1	$20.4M	Hold	1,475,840	–	–	0.44%	47
2020 Q4	$21M	Sell	1,475,840 -370,855	-20%	-$4.99M	0.52%	45
2020 Q3	$23.9M	Sell	1,846,695 -1,175	-0.1%	-$14K	0.83%	40
2020 Q2	$19.6M	Sell	1,847,870 -489,560	-21%	-$4.98M	0.7%	44
2020 Q1	$18.9M	Sell	2,337,430 -570	-0%	-$4.75K	0.66%	40
2019 Q4	$19M	Sell	2,338,000 -423,605	-15%	-$3.35M	0.5%	40
2019 Q3	$20.9M	Sell	2,761,605 -93,375	-3%	-$695K	0.67%	40
2019 Q2	$21.4M	Sell	2,854,980 -190,955	-6%	-$1.5M	0.68%	40
2019 Q1	$24.7M	Buy	3,045,935 +136,300	+5%	+$1.04M	0.78%	40
2018 Q4	$21.9M	Sell	2,909,635 -372,740	-11%	-$2.62M	0.81%	40
2018 Q3	$22.7M	Sell	3,282,375 -514,720	-14%	-$3.44M	0.71%	41
2018 Q2	$24.5M	Buy	3,797,095 +2,765	+0.1%	+$17.4K	0.71%	39
2018 Q1	$24.5M	Buy	3,794,330 +2,010,400	+113%	+$14.1M	0.67%	42
2017 Q4	$13.4M	Buy	1,783,930 +1,778,430	+32,335%	+$12.8M	0.33%	48
2017 Q3	$39K	Hold	5,500	–	–	﹤0.01%	118
2017 Q2	$46K	Buy	5,500 +1,000	+22%	+$8.13K	﹤0.01%	114
2017 Q1	$36K	Buy	4,500 +1,000	+29%	+$8.64K	﹤0.01%	121
2016 Q4	$32K	Hold	3,500	–	–	﹤0.01%	122
2016 Q3	$32K	Sell	3,500 -2,000	-36%	-$19.1K	﹤0.01%	126
2016 Q2	$56K	Hold	5,500	–	–	﹤0.01%	114
2016 Q1	$50K	Hold	5,500	–	–	﹤0.01%	123
2015 Q4	$51K	Sell	5,500 -7,000	-56%	-$76.7K	﹤0.01%	85
2015 Q3	$160K	Hold	12,500	–	–	﹤0.01%	68
2015 Q2	$138K	Buy	12,500 +2,000	+19%	+$22.1K	﹤0.01%	66
2015 Q1	$120K	Buy	10,500 +3,500	+50%	+$37.1K	﹤0.01%	67
2014 Q4	$71K	Hold	7,000	–	–	﹤0.01%	66
2014 Q3	$74K	Buy	+7,000	New	+$65.8K	﹤0.01%	64

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mondrian Investment Partners's RDY Position: Q1 2025 in Review

Mondrian Investment Partners reduced its Dr. Reddy's Laboratories (RDY) stake by 0.62% in Q1 2025, selling an estimated $55.5K and leaving 644,794 shares worth $8.5M. The position accounts for 0.15% of the portfolio, ranked #54.

Mondrian Investment Partners first reported a position in RDY in Q3 2014 and has held it in 43 quarters since. The position peaked at $24.7M in Q1 2019. 243 funds tracked by Wall St. Rank hold RDY as of Q1 2025.

Mondrian Investment Partners held 644,794 shares of Dr. Reddy's Laboratories worth $8.5M as of Q1 2025.
Mondrian Investment Partners sold 4,019 Dr. Reddy's Laboratories shares in Q1 2025, an estimated $55.5K.
Dr. Reddy's Laboratories made up 0.15% of Mondrian Investment Partners's portfolio in Q1 2025, its #54 holding.
Mondrian Investment Partners first reported a position in Dr. Reddy's Laboratories in Q3 2014 and has held it in 43 quarters since.
Mondrian Investment Partners's Dr. Reddy's Laboratories position peaked at $24.7M in Q1 2019.
243 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2025.

Based on Mondrian Investment Partners's 13F filing for Q1 2025, filed 13 May 2025.